Accéder au contenu
Merck

Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii.

International journal for parasitology (2002-06-14)
Nahid Azzouz, Beatrice Rauscher, Peter Gerold, Marie-France Cesbron-Delauw, Jean-François Dubremetz, Ralph T Schwarz
RÉSUMÉ

Glycolipids are important components of cellular membranes involved in various biological functions. In this report, we describe the identification of the de novo synthesis of glycosphingolipids by Toxoplasma gondii tachyzoites. Parasite-specific glycolipids were identified by metabolic labelling of parasites with tritiated serine and galactose. These glycolipids were characterised as sphingolipids based on the labelling protocol and their insensitivity towards alkaline treatment. Synthesis of parasite glycosphingolipids were inhibited by threo-phenyl-2-palmitoylamino-3-morpholino-1-propanol and L-cycloserine, two well-established inhibitors of de novo sphingolipid biosynthesis. The identified glycolipids were insensitive towards treatment with endoglycoceramidase II indicating that they might belong to globo-type glycosphingolipids. Taken together, we provide evidence for the first time that T. gondii is capable of synthesising glycosphingolipids de novo.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Endoglycoceramidase II from Rhodococcus sp., aqueous solution